| Health Care Equipment & Supplies Industry | Healthcare Sector | Wonsoo Yun CEO | KRX SM Exchange | KR7246710008 ISIN |
| KR Country | 86 Employees | - Last Dividend | 5 Apr 2022 Last Split | - IPO Date |
T&R Biofab Co., Ltd. is a pioneering company focused on the research and development of advanced medical devices intended for transplantation and tissue regeneration across multiple medical fields such as orthopedics, plastic surgery, and dentistry. The company's innovative approach is centered on harnessing the potential of 3D bioprinting and regenerative medicine to offer solutions that improve patient outcomes and enhance the quality of life. Founded in 2013, T&R Biofab has established its headquarters in Siheung-si, South Korea, positioning itself as a leader in the fast-evolving biofabrication industry.
These are specialized medical devices designed for use in surgeries related to the cranial and facial areas. T&R Biofab utilizes cutting-edge technology to produce meshes that offer improved integration with the patient's tissues, leading to enhanced recovery times and outcomes.
Dental meshes developed by T&R Biofab are utilized for various dental surgeries, including those that require bone grafting. These products are designed to support the regeneration of dental tissues and structures, ensuring patient-specific fit and optimal recovery.
The company produces custom-made implants tailored to the specific needs and anatomies of patients. These implants find applications in several areas of medicine, offering personalized solutions that significantly improve surgical success rates and patient satisfaction.
T&R Biofab is at the forefront of 3D bioprinting technology, developing bioinks that are used to create tissue models and organoids. These bioinks are crucial for regenerative medicine research and have applications in drug development, toxicity testing, and eventually, organ transplantation.
The company provides advanced solutions for stem cell research, including the development of platforms for cell culture and delivery. These technologies are integral to the advancement of regenerative medicine, enabling researchers to cultivate and manipulate stem cells in ways that were previously not possible.
T&R Biofab offers innovative coating solutions for scaffolds and culture dishes, enhancing cell attachment and growth. These coatings are essential for the successful culture of cells and tissue engineering, paving the way for breakthroughs in tissue regeneration and transplantation.